Presentation TCT 2019 LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials Presenter: Vivek Reddy September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the Evolut Low-Risk Trial Presenter: Michael Reardon September 26, 2019
Presentation TCT 2019 Poly-Genetic Risk Analysis, Big Data Analytics, and Disease Prediction Models Presenter: Robert Califf September 26, 2019
Presentation TCT 2019 Can We and Should We Use FFR/IFR/qFR to Guide the Bifurcation Strategy? Presenter: Bon-Kwon Koo September 26, 2019
Presentation TCT 2019 Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept Presenter: William Maisel September 26, 2019
Presentation TCT 2019 Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED Presenter: Edip Gurol September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the PARTNER 3 Trial Presenter: Martin Leon September 26, 2019
Presentation TCT 2019 Step-by-Step IVUS: From Pre-Intervention Through Stent Optimization to Assessment of Complications Presenter: Andrew Sharp September 26, 2019
Presentation TCT 2019 When Is a Side Branch Clinically Relevant? Presenter: Yves Louvard September 26, 2019